Pablo Menéndez

Institució Catalana de Recerca i Estudis Avançats — Spain

Biochemistry, Genetics and Molecular Biology · Life Sciences

64h-index14.4kcitations517works4.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pluripotent Stem Cells Research(77), Acute Lymphoblastic Leukemia research(77), Acute Myeloid Leukemia Research(74), CAR-T cell therapy research(72), CRISPR and Genetic Engineering(57)

Publications513 total

Early intrinsic excitability plasticity of neocortical engram neurons defines memory formation and precision
Nature Communications·2025Open Access
Lipid nanoparticle-based delivery of gene therapy targeting the RUNX1::RUNX1T1 fusion oncogene in acute myeloid leukemia
Blood·2025
3138 – LIMS1 REGULATES ACUTE MYELOID LEUKEMIA INITIATION THROUGH CELL ADHESION INTERACTIONS AND MIGRATION OF LEUKEMIC STEM CELLS
Experimental Hematology·2025
3235 – HYPERDIPLOIDY IMPAIRS FETAL HSPC FITNESS AND DIFFERENTIATION ENABLING LONG-TERM PERSISTENCE OF RARE PRELEUKEMIC TRISOMIC CLONES IN BONE MARROW
Experimental Hematology·2025
3022 – COMPARING IN VITRO HUMAN PLURIPOTENT STEM CELL MODELS TO ASSESS HEMATOPOIETIC DEVELOPMENT
Experimental Hematology·2025
Author response: Chromatin activity of IκBα mediates the exit from naïve pluripotency
2025Open Access
The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia
Nature Communications·2025· 2 citedOpen Access
Chromatin activity of IκBα mediates the exit from naïve pluripotency
eLife·2025Open Access
A platform of robust patient-derived leukemia models covering subgroups for which no cell lines exist
2025Open Access
Chromatin activity of IκBα mediates the exit from naïve pluripotency
2025Open Access
Author response: Chromatin activity of IκBα mediates the exit from naïve pluripotency
2025Open Access
A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias
Leukemia·2025Open Access
HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia
Biomarker Research·2025Open Access
Ultrasound Study of Trocar Site Hernia after Bariatric Surgery: Medium and Long-Term Follow-Up
Journal of Abdominal Wall Surgery·2025Open Access
CAR-T cell therapy for cancer: current challenges and future directions
Signal Transduction and Targeted Therapy·2025· 89 citedOpen Access
Orthopaedic heritage in seventeenth Century Dutch and Flemish genre painting
International Orthopaedics·2025
CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia
Journal of Hematology & Oncology·2025· 7 citedOpen Access
A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression
Nature Communications·2025· 2 citedOpen Access
Characterization of childhood B-ALL cell lines to identify novel CIN-targeted therapies
Klinische Pädiatrie·2025
RACK1 as a novel therapeutic target against Acute Myeloid Leukemia stem cells
Klinische Pädiatrie·2025
page 1 of 26Next →

Frequent Co-authors

Clara Bueno(24), René Rodrı́guez(10), Javier Garcı́a-Castro(9), Ruth Rubio(7), Mickie Bhatia(6), Iván Gutiérrez-Aranda(6), Laura Sánchez(6), Verónica Ramos–Mejía(5), Purificación Catalina(5), Rosa Montes(5), Paola Ballerini(4), Giovanni Cazzaniga(4), Rolf Marschalek(4), Gertrudis Ligero(4), Julio Castaño(4), Claus Meyer(3), Thomas Burmeister(3), Daniela Gröger(3), Grigory Tsaur(3), Л. Г. Фечина(3)